RESPIMMUNE Trademark

Trademark Overview

On Friday, March 4, 2011, a trademark application was filed for RESPIMMUNE with the United States Patent and Trademark Office. The USPTO has given the RESPIMMUNE trademark a serial number of 85258047. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 27, 2014. This trademark is owned by ADMA Biologics Inc.. The RESPIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immune system related diseases and disorders
respimmune

General Information

Serial Number85258047
Word MarkRESPIMMUNE
Filing DateFriday, March 4, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 27, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 9, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADMA Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRamsey, NJ 07446
Party NameADMA Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601

Trademark Events

Event DateEvent Description
Monday, October 27, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 27, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2014EXTENSION 5 GRANTED
Thursday, March 20, 2014EXTENSION 5 FILED
Thursday, April 24, 2014NOTICE OF REVIVAL - E-MAILED
Thursday, April 24, 2014EXTENSION RECEIVED WITH TEAS PETITION
Thursday, April 24, 2014PETITION TO REVIVE-GRANTED
Thursday, April 24, 2014TEAS PETITION TO REVIVE RECEIVED
Monday, April 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 21, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2013EXTENSION 4 GRANTED
Wednesday, September 4, 2013EXTENSION 4 FILED
Wednesday, September 4, 2013TEAS EXTENSION RECEIVED
Thursday, March 28, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 27, 2013EXTENSION 3 GRANTED
Friday, March 8, 2013EXTENSION 3 FILED
Tuesday, March 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 8, 2013TEAS EXTENSION RECEIVED
Tuesday, September 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 10, 2012EXTENSION 2 GRANTED
Tuesday, September 4, 2012EXTENSION 2 FILED
Thursday, September 6, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 4, 2012TEAS EXTENSION RECEIVED
Wednesday, March 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 5, 2012EXTENSION 1 GRANTED
Monday, March 5, 2012EXTENSION 1 FILED
Monday, March 5, 2012TEAS EXTENSION RECEIVED
Tuesday, September 20, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2011PUBLISHED FOR OPPOSITION
Thursday, June 9, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 6, 2011ASSIGNED TO EXAMINER
Wednesday, March 9, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 8, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

respimmune related diseases disorders system immune preparations treatment pharmaceutical